Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2975 of 3173 entries
View as:

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

Phase: N/A Priority: Normal
NCT ID: NCT00661635 Org: User:
Start: 11/30/02 End: 07/31/03 Due: 07/31/04

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02312037 Org: User:
Start: - End: - Due: -

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT05471505 Org: User:
Start: 08/25/22 End: 09/27/22 Due: 09/27/23

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT00134173 Org: User:
Start: 10/31/03 End: 09/30/06 Due: 09/30/07

Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

Phase: N/A Priority: Normal
NCT ID: NCT06487078 Org: User:
Start: 01/20/25 End: 11/30/28 Due: 11/30/29

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01163838 Org: User:
Start: 08/31/10 End: 03/31/11 Due: 03/31/12

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03469336 Org: User:
Start: 04/24/18 End: 03/20/19 Due: 03/20/20

Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)

Phase: N/A Priority: Normal
NCT ID: NCT02222441 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05923411 Org: User:
Start: 07/11/23 End: 07/19/24 Due: 07/19/25

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04655040 Org: User:
Start: 12/18/20 End: 03/05/21 Due: 03/05/22

A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04325698 Org: User:
Start: 06/11/20 End: 05/10/21 Due: 05/10/22

A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05890105 Org: User:
Start: 06/02/23 End: 12/01/23 Due: 12/01/24

Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04627532 Org: User:
Start: 10/23/20 End: 12/17/20 Due: 12/17/21

A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

Phase: N/A Priority: Normal
NCT ID: NCT04822350 Org: User:
Start: 07/13/21 End: 04/25/24 Due: 04/25/25

A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377

Phase: N/A Priority: Normal
NCT ID: NCT02005991 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT02045732 Org: User:
Start: 09/30/14 End: 10/31/15 Due: 10/31/16

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01210495 Org: User:
Start: 12/06/10 End: 12/20/16 Due: 12/20/17

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Phase: N/A Priority: Normal
NCT ID: NCT01628107 Org: User:
Start: 07/16/12 End: 01/02/15 Due: 01/02/16

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01286467 Org: User:
Start: 05/11/11 End: 12/28/12 Due: 12/28/13

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Phase: N/A Priority: Normal
NCT ID: NCT02501928 Org: User:
Start: 06/05/15 End: 04/01/20 Due: 04/01/21

The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT00694161 Org: User:
Start: 08/31/08 End: 01/31/10 Due: 01/31/11

A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV

Phase: N/A Priority: Normal
NCT ID: NCT06102174 Org: User:
Start: 02/15/24 End: 09/03/24 Due: 09/03/25

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03812835 Org: User:
Start: 08/23/21 End: 08/23/23 Due: 08/23/24

Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00793871 Org: User:
Start: 11/30/08 End: 10/31/14 Due: 10/31/15

Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02224651 Org: User:
Start: 09/30/14 End: 06/30/15 Due: 06/30/16